Basaloid-squamous carcinoma of the esophagus treated by preoperative chemotherapy: Report of two cases

Surgery Today

Volumn 33, Issue 6, 2003, Pages 444-447

  Koide, Naohiko ^a   Kishimoto, Kyo ^a   Nakamura, Toshiyuki ^a   Igarashi, Jun ^a   Maezawa, Tsuyoshi ^b   Hanazaki, Kazuhiro ^a   Adachi, Wataru ^a   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Maezawa Hospital   (Japan)

Author keywords

5 Fluorouracil; Basaloid squamous carcinoma; Chemotherapy; Cisplatin; Esophagus

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; ESOPHAGOGRAPHY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; PREOPERATIVE TREATMENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION ROUTES; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED;

EID: 0038697664     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10595-002-2511-2     Document Type: Article

References (10)

1. Mustard RA, Ibberson O. Carcinoma of the esophagus. A review of 381 cases admitted to Toronto General Hospital 1937-1953 inclusive. Ann Surg 1956;144:927-40.
2. Suzuki H, Nagayo T. Primary tumors of the esophagus other than squamous cell carcinoma: Histologic classification and statistics in the surgical and autopsied materials in Japan. Int Adv Surg Oncol 1980;3:73-109.
3. Kato T, Morita T, Fujita M, Miyasaka Y, Horita S, Watanabe Y, et al. Basaloid-squamous carcinoma of the esophagus: report of a case. Surg Today 2000;30:163-7.
4. Takubo K, Mafune K, Tanaka Y, Miyama T, Fujita K. Basaloid-squamous carcinoma of the esophagus with marked deposition of basement membrane substance. Acta Pathol Jpn 1991;41:59-64.
5. Sekiguchi H, Akiyama S, Fujiwara M, Nakamura H, Kondo K, Kasai Y. et al. Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus. Surg Today 1999;29:97-101.
6. Koide N, Koike S, Watanabe H, Yazawa K, Adachi W, Amano J. Basaloid squamous carcinoma of the esophagus with analysis by in situ nick end labeling and PCNA immunostaining. Hepato-Gastroenterology 1999;46:265-71.
7. Koide N, Koike S, Adachi W, Amano J, Usuda N, Nagata T. Immunohistochemical expression of bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the esophagus. Surg Today 1997;27:685-91.
8. Koide N, Nishio A, Kono T, Hiraguri M, Watanabe H, Igarashi J, et al. Histochemical study of angiogenesis in basaloid squamous carcinoma of the esophagus. Dis Esophagus 12:142-7.
9. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma - final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001;91:2165-74.
10. Tsuchiya Y, Onda M, Miyashita M, Hagiwara N, Maruyama H, Matsutani T, et al. Combined modality therapy for basaloid squamous carcinoma of the esophagus. Hepato-Gastroenterology 1999;46:2868-71.